SMTI SCHEDULE 13G: SEC filing
Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC
Filed with the SEC on · accession 0000886982-26-000562
SMTI filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 9, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +1.7% by the first close after the filing.
Summary of the filing
Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of approximately 5.0% of Sanara MedTech Inc.'s common stock as of September 30, 2026, held in the ordinary course of business without intent to influence control.
Key details
How SMTI stock reacted
Close before
$31.55
Nov 6, 2026
First close after
+1.74%
$32.10
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SMTI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SMTI?
Click hereFrequently asked questions
What did SMTI file with the SEC on Nov 9, 2026?
SMTI filed a SCHEDULE 13G (SEC filing). Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of approximately 5.0% of Sanara MedTech Inc.'s common stock as of September 30, 2026, held in the ordinary course of business without intent to influence control.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did SMTI stock react to this filing?
SMTI closed at $31.55 before the filing and $32.10 on Nov 9, 2026 (+1.74%).
Other SMTI SEC filings
Get alerts when SMTI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days